The DOI matches its Crossref record.
Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra‐pancreatic glucose regulation
Abstract
Aim: The present investigation was designed to determine the in vivo antidiabetic effect of naringenin (NG) in normoglycaemic and diabetic rat models through blood glucose (GLU) measurements following acute and subchronic time periods. Possible modes of action of NG were investigated and its acute toxicity determined. Methods: Normoglycaemic and non‐insulin‐dependent diabetes mellitus (NIDDM) rat models were treated for acute and subchronic (5 days) time periods with 50 mg/kg/day of NG. Blood biochemical profiles were determined after 5 days of the treatment in normoglycaemic and NIDDM rats using commercial kits for GLU, triglycerides (TG), total cholesterol (CHOL) and high‐density lipoprotein (HDL). In order to elucidate its antidiabetic mode of action, NG was administered intragastrically and an oral glucose tolerance test performed using GLU and sucrose (2 g/kg) as substrates. The inhibitory effect of a single concentration of NG (10 μM) on 11β‐hydroxysteroid dehydrogenase type 1 (11β‐HSD1) activity in vitro was determined. Finally, the preclinical safety and tolerability of NG was determined by toxicological evaluation in mice and rats using Organization for Economic Cooperation and Development (OECD) protocols. Results: Intragastrically administered NG (50 mg/kg) induced a significant decrease in plasma GLU in normoglycaemic and NIDDM rat models (p < 0.05) following acute and subchronic time periods. After 5 days of administration, NG produced significant diminished blood GLU and TG levels in streptozotocin–nicotinamide–induced diabetic rats. The administration of NG to normal rats significantly increased the levels of TG, CHOL and HDL (p < 0.05). NG (5 and 50 mg/kg) induced a total suppression in the increase of plasma GLU levels after administration of substrates (p < 0.01), but NG did not produce inhibition of α‐glucosidase activity in vitro . However, NG (10 μM) was shown to inhibit 11β‐HSD1 activity by 39.49% in a cellular enzyme assay. Finally, NG showed a Medium Lethal Dose LD 50 > 5000 mg/kg and ranking at level five based on OECD protocols. Conclusion: Our findings suggest that NG may exert its antidiabetic effect by extra‐pancreatic action and by suppressing carbohydrate absorption from intestine, thereby reducing the postprandial increase in blood GLU levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Streptozotocin–nicotinamide-induced diabetes in the rat. Characteristics of the experimental model
Szkudelski, T. (2012) · Experimental Biology and Medicine · doi:10.1258/ebm.2012.011372 · Cited by 436
Beneficial effects of naringenin in liver diseases: Molecular mechanisms
Hernández-Aquino, E., & Muriel, P. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i16.1679 · Cited by 347
Pharmacokinetic, pharmacodynamic and formulations aspects of Naringenin: An update
Joshi, R., Kulkarni, Y. A., & Wairkar, S. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.10.066 · Cited by 278
Streptozotocin-nicotinamide-induced rat model of type 2 diabetes (review)
Ghasemi, A., Khalifi, S., & Jedi, S. (2014) · Acta Physiologica Hungarica · doi:10.1556/aphysiol.101.2014.4.2 · Cited by 274
Antidiabetic Properties of Naringenin: A Citrus Fruit Polyphenol
Den Hartogh, D. J., & Tsiani, E. (2019) · Biomolecules · doi:10.3390/biom9030099 · Cited by 267
Metadata
- Authors
- Ortiz‐Andrade, R. R., Sánchez‐Salgado, J. C., Navarrete‐Vázquez, G., Webster, S. P., Binnie, M., García‐Jiménez, S., León‐Rivera, I., Cigarroa‐Vázquez, P., Villalobos‐Molina, R., & Estrada‐Soto, S.
- Venue
- Diabetes, Obesity and Metabolism
- Publisher
- Wiley
- Published
- 2008-10-14
- Volume
- 10
- Issue
- 11
- Pages
- 1097-1104
- ISSN
- 1462-8902 (ISSN-L)
- 1463-1326
- OpenAlex
- W2165809374
- Cited by
- 178
- References
- 0
- FWCI
- 2.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra‐pancreatic glucose regulation. https://app.cochat.ai/papers/10.1111/j.1463-1326.2008.00869.x
- The paper
- Ortiz‐Andrade, R. R., Sánchez‐Salgado, J. C., Navarrete‐Vázquez, G., Webster, S. P., Binnie, M., García‐Jiménez, S., León‐Rivera, I., Cigarroa‐Vázquez, P., Villalobos‐Molina, R., & Estrada‐Soto, S. (2008). Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra‐pancreatic glucose regulation. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/j.1463-1326.2008.00869.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.